Merck & Co Inc

NYSE: MRK
$99.25
-$0.60 (-0.6%)
Closing Price on January 10, 2025

MRK Articles

Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was a big win for Merck.
Merck reported better-than-expected second-quarter 2016 results before markets opened Friday morning.
The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest was mixed.
Overall, one-third of the Dow Jones Industrial Average is reporting this week, and this has the potential to sustain the run that the Dow has made since the Brexit vote.
The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest decreased.
July 6, 2016: Markets opened lower again Wednesday, following international markets that traded lower overnight. The British pound posted a new 31-year low against the dollar before climbing back a...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The broad markets are recovering in the wake of the...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. June 29, 2016: Markets opened higher again Wednesday and...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The short interest data have been released for the June...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. June 17, 2016: Markets opened lower again Friday after a...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. June 16, 2016: Markets opened lower Thursday but...
Merck and Afferent Pharmaceuticals reportedly have signed a definitive agreement under which the former will acquire the latter.
The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations at the conference.
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it is looking for.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.